⏱ News is delayed by 15 minutes. Sign in for real-time access.
Sign in
PLRZ News
Polyrizon Ltd. Ordinary Shares
Moonage Media Spotlights Polyrizon (Nasdaq: PLRZ): Unveils NASARIX™, Drug-Free Allergy Blocker
prnewswire.com
PLRZ
Polyrizon Intends to Secure Controlling Stake in Profitable Private Jet Operator
globenewswire.com
PLRZ
Taurus Gold Corp. Management Updates Ready to Announce with Confidence?
newsfilecorp.com
CMND
NITO
PLRZ
IMCC
Clearmind Medicine Enters into Development Agreement to Advance Intranasal Formulation for its Proprietary Non-Hallucinogenic Neuroplastogen MEAI
globenewswire.com
PLRZ
CMND
Polyrizon Signs an Agreement to Develop Intranasal Proprietary Non-Hallucinogenic Neuroplastogen Formulation
globenewswire.com
PLRZ
CMND
Polyrizon Intends to Acquire 51% Stake in Global Private Aviation Company
globenewswire.com
PLRZ
Polyrizon Advances Regulatory Path with Initiation of Usability Study Program for NASARIX™ Allergy Blocker
globenewswire.com
PLRZ
Polyrizon to Explore Revenue-Generating Investment Opportunities in High-Growth Sectors, Leveraging Strong Cash Position and Debt-Free Balance Sheet
globenewswire.com
PLRZ
Polyrizon Completes Branding Process for PL-14 Allergy Blocker with Brand Name NASARIX™
globenewswire.com
PLRZ
Polyrizon Announces New Pre-Clinical Results: PL-14 Demonstrates Significant Allergen-Blocking Performance Compared to a Standard Comparator
globenewswire.com
PLRZ